Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon.

Recombinant alpha-2b interferon was evaluated in two controlled trials, each lasting for 2 months or more, with different dose levels and schedules of administration. The first study was conducted during a period of transmission of type A (H1N1) and type B influenza. At 2.5 x 10(6) IU per day, no ef...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Monto, A S, Albrecht, J K, Schwartz, S A
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1988
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172096/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2831814/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.1.47
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!